Analyst Upgrades Valeant Stock to Buy

However, most other analysts have not been so optimistic

Managing Editor
May 15, 2018 at 9:46 AM
facebook X logo linkedin


Shares of drug name Valeant Pharmaceuticals Intl Inc (NYSE:VRX) are trading higher this morning, after the stock received an upgrade from Mizuho to "buy" from "neutral" and a price-target hike to $27 from $15, with the analyst in coverage calling the company's portfolio "Mylan-like." In response, VRX is up 2.8% at $21.40, at last check.

Longer term, VRX stock has been flying up the charts since bottoming out at a near-term low of $14.96 in early April, adding 43% -- most recently, thanks to an earnings bull gap. Today's pop has the security trading above the $21 level for the first time since late January. 

Other analysts have not been so optimistic toward Valeant stock, however, with the average 12-month target price target coming in at $20.38 -- a discount to current levels. Further, of the 12 brokerage firms covering VRX, seven sport "hold" or "strong sell" recommendations. More bullish brokerage notes could help keep the wind at the equity's back.

Those looking to bet on Valeant's near-term trajectory with options are in luck, too. The stock's Schaeffer's Volatility Index (SVI) of 0.39 ranks in the lowest annual percentile, suggesting short-term options have rarely been cheaper, from a volatility standpoint.

It's also worth noting that Valeant stock sports a Schaeffer's Volatility Scorecard (SVS) of 99 out of 100. This higher ranking means the equity has tended to register bigger price swings than its options premiums have priced in over the past 12 months.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI